BeStock  
Stocks › Biotechnology › AUPH

Aurinia Pharmaceuticals AUPH

US equityMarket cap rank #2690Biotechnology
$14.70 −$0.19 (-1.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.64 -0.41%
Open$14.69
Prev close$14.89
Day range$14.63 – $14.97
Volume1.34M
Market cap$1.97B
P/E (TTM)6.4
Dividend yield–

AUPH Stock News

Headlines matching Aurinia Pharmaceuticals or the AUPH ticker, most recent first.

  • Earnings Flash (AUPH) Aurinia Pharmaceuticals Inc. Reports Q2 Revenue $83.2M, Vs. FactSet Est of $80.4MMT Newswires · 6 Aug 2026 · Direct mention
  • TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $17Market news · 20 Aug 2026 · Direct mention
  • Bloom Burton Upgrades Aurinia Pharmaceuticals(AUPH.US) to Buy Rating, Raises Target Price to $21 PositiveMarket news · 20 Aug 2026 · Direct mention
  • Aurinia Pharmaceuticals(AUPH.US) 10% Shareholder Buys US$12.46 Million in Common StockMarket news · 3 Jun 2026 · Direct mention
  • Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q1 EPS $0.25, Vs. FactSet Est of $0.20MT Newswires · 7 May 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Neumora Therapeutics, Inc. (NMRA) and Aurinia Pharmaceuticals (AUPH)TipRanks · 31 Mar 2026 · Direct mention
  • Bloom Burton Maintains Aurinia Pharmaceuticals(AUPH.US) With Hold Rating, Maintains Target Price $15Market news · 31 Mar 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH), MAIA Biotechnology, Inc. (MAIA) and CG Oncology, Inc. (CGON)TipRanks · 2 Mar 2026 · Direct mention
  • RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Hold Rating, Maintains Target Price $15Market news · 27 Feb 2026 · Direct mention
  • H.C. Wainwright Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $17Market news · 27 Feb 2026 · Direct mention
  • Bloom Burton Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $21Market news · 3 Nov 2026 · Direct mention
  • Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q3 EPS $0.23, Vs. FactSet Est of $0.22MT Newswires · 30 Oct 2026 · Direct mention
  • Earnings Flash (AUPH) Aurinia Pharmaceuticals Inc. Reports Q3 Revenue $83.7M, Vs. FactSet Est of $83.6MMT Newswires · 30 Oct 2026 · Direct mention
  • TR | OpenAI - 4o Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $13 PositiveMarket news · 6 Aug 2025 · Direct mention
  • TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $11Market news · 1 Aug 2025 · Direct mention

Discussion

No comments yet — be the first to weigh in on AUPH.

Sign in to join the discussion.

Scroll to Top